Mutant huntingtin-impaired degradation of β-catenin causes neurotoxicity in Huntington's disease
Open Access
- 8 June 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 29 (14), 2433-2445
- https://doi.org/10.1038/emboj.2010.117
Abstract
Huntington's disease (HD) is a fatal neurodegenerative disorder causing selective neuronal death in the brain. Dysfunction of the ubiquitin–proteasome system may contribute to the disease; however, the exact mechanisms are still unknown. We report here a new pathological mechanism by which mutant huntingtin specifically interferes with the degradation of β‐catenin. Huntingtin associates with the β‐catenin destruction complex that ensures its equilibrated degradation. The binding of β‐catenin to the destruction complex is altered in HD, leading to the toxic stabilization of β‐catenin. As a consequence, the β‐transducin repeat‐containing protein (β‐TrCP) rescues polyglutamine (polyQ)‐huntingtin‐induced toxicity in striatal neurons and in a Drosophila model of HD, through the specific degradation of β‐catenin. Finally, the non‐steroidal anti‐inflammatory drug indomethacin that decreases β‐catenin levels has a neuroprotective effect in a neuronal model of HD and in Drosophila and increases the lifespan of HD flies. We thus suggest that restoring β‐catenin homeostasis in HD is of therapeutic interest.Keywords
This publication has 64 references indexed in Scilit:
- Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairmentProceedings of the National Academy of Sciences of the United States of America, 2009
- Regulator of Calcineurin (RCAN1-1L) Is Deficient in Huntington Disease and Protective against Mutant Huntingtin Toxicity in VitroJournal of Biological Chemistry, 2009
- The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's DiseasePLOS ONE, 2009
- Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease miceNeuroscience, 2008
- Feedback Regulation between Zipcode Binding Protein 1 and β-Catenin mRNAs in Breast Cancer CellsMolecular and Cellular Biology, 2008
- SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradationNature, 2008
- Huntingtin Interacting Proteins Are Genetic Modifiers of NeurodegenerationPLoS Genetics, 2007
- Targeted degradation of β-catenin by chimeric F-box fusion proteinsBiochemical and Biophysical Research Communications, 2004
- Structure of a β-TrCP1-Skp1-β-Catenin Complex: Destruction Motif Binding and Lysine Specificity of the SCFβ-TrCP1 Ubiquitin LigaseMolecular Cell, 2003
- The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-cateninOncogene, 1999